211 related articles for article (PubMed ID: 22558946)
1. Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study.
Kall MM; Coyne KM; Garrett NJ; Boyd AE; Ashcroft AT; Reeves I; Anderson J; Bothamley GH
BMC Infect Dis; 2012 May; 12():107. PubMed ID: 22558946
[TBL] [Abstract][Full Text] [Related]
2. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
[TBL] [Abstract][Full Text] [Related]
3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
4. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
Binay UD; Fincancı M; Fersan E; Karakeçili F
Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.
Cheallaigh CN; Fitzgerald I; Grace J; Singh GJ; El-Eraki N; Gibbons N; Keane J; Rogers TR; Clarke S; Bergin C
PLoS One; 2013; 8(1):e53330. PubMed ID: 23382842
[TBL] [Abstract][Full Text] [Related]
8. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting.
Mandalakas AM; Kirchner HL; Walzl G; Gie RP; Schaaf HS; Cotton MF; Grewal HM; Hesseling AC
Am J Respir Crit Care Med; 2015 Apr; 191(7):820-30. PubMed ID: 25622087
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
11. Good Agreement between an Interferon Gamma Release Assay and Tuberculin Skin Tests in Testing for Latent Tuberculosis Infection among HIV-Infected Patients in Indonesia.
Reviono R; Saptawati L; Redhono D; Suryawati B
J Korean Med Sci; 2019 Oct; 34(40):e259. PubMed ID: 31625291
[TBL] [Abstract][Full Text] [Related]
12. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
13. Treatment of latent tuberculosis infection in HIV infected persons.
Akolo C; Adetifa I; Shepperd S; Volmink J
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000171. PubMed ID: 20091503
[TBL] [Abstract][Full Text] [Related]
14. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
[TBL] [Abstract][Full Text] [Related]
15. Performance of the QuantiFERON-TB gold interferon gamma release assay among HIV-infected children in Botswana.
Cruz AT; Marape M; Graviss EA; Starke JR
J Int Assoc Provid AIDS Care; 2015; 14(1):4-7. PubMed ID: 25149414
[TBL] [Abstract][Full Text] [Related]
16. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study.
Lee SS; Lin HH; Tsai HC; Su IJ; Yang CH; Sun HY; Hung CC; Sy CL; Wu KS; Chen JK; Chen YS; Fang CT
PLoS One; 2015; 10(8):e0135801. PubMed ID: 26280669
[TBL] [Abstract][Full Text] [Related]
17. Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong.
Leung CC; Chan K; Yam WC; Lee MP; Chan CK; Wong KH; Ho PL; Mak I; Tam CM
Respirology; 2016 Oct; 21(7):1322-9. PubMed ID: 27121551
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment.
Oni T; Gideon HP; Bangani N; Tsekela R; Seldon R; Wood K; Wilkinson KA; Goliath RT; Ottenhoff TH; Wilkinson RJ
Clin Vaccine Immunol; 2012 Aug; 19(8):1243-7. PubMed ID: 22718129
[TBL] [Abstract][Full Text] [Related]
19. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.
Jiang W; Shao L; Zhang Y; Zhang S; Meng C; Xu Y; Huang L; Wang Y; Wang Y; Weng X; Zhang W
BMC Immunol; 2009 May; 10():31. PubMed ID: 19476627
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
